Stereoselective regulation of MDR1 expression in Caco‐2 cells by cetirizine enantiomers
- 29 March 2007
- Vol. 19 (6) , 485-490
- https://doi.org/10.1002/chir.20400
Abstract
MDR1‐encoded P‐glycoprotein (P‐gp) is a drug efflux transporter mainly expressed in liver, kidney, intestine, brain (at the level of the blood‐brain barrier), and placenta. It thus plays important roles in drug absorption, distribution, and excretion. Cetirizine is a second‐generation nonsedating antihistamine used to treat allergic disease of respiratory system, skin and eyes. To evaluate P‐gp expression and function in Caco‐2 cells pretreated with cetirizine enantiomers, we assessed the sensitivity of Caco‐2 cells to paclitaxel using the MTT assay and the polarized transport of rhodamine‐123 and doxorubicin across Caco‐2 monolayers. RT‐PCR and flow cytometry were used to assay MDR1 mRNA and P‐gp protein respectively. The sensitivity of Caco‐2 cells to paclitaxel decreased significantly after cells were pretreated with 100 μM R‐cetirizine but increased upon treatment with S‐cetirizine. The efflux of rhodamine‐123 and doxorubicin was enhanced significantly after Caco‐2 monolayers were pretreated with 100 μM R‐cetirizine but was reduced by S‐cetirizine. The MDR1 mRNA and P‐gp levels in Caco‐2 cells were increased by 100 μM R‐cetirizine and decreased by 100 μM S‐cetirizine. These results suggest that R‐cetirizine up‐regulates MDR1 expression while S‐cetirizine down‐regulates MDR1 expression. Chirality, 2007.Keywords
This publication has 23 references indexed in Scilit:
- Effects of capsaicin on P-gp function and expression in Caco-2 cellsBiochemical Pharmacology, 2006
- Up-regulation of MDR1 and induction of doxorubicin resistance by histone deacetylase inhibitor depsipeptide (FK228) and ATRA in acute promyelocytic leukemia cellsBlood, 2006
- Determination of the stereoselectivity of chiral drug transport across Caco‐2 cell monolayersChirality, 2005
- Inhibition of P-glycoprotein by natural products in human breast cancer cellsArchives of Pharmacal Research, 2005
- P‐glycoprotein Influences the Brain Concentrations of Cetirizine (Zyrtec®), a Second‐Generation Non‐Sedating AntihistamineJournal of Pharmaceutical Sciences, 2003
- Digoxin up-regulates multidrug resistance transporter (MDR1) mRNA and simultaneously down-regulates steroid xenobiotic receptor mRNABiochemical and Biophysical Research Communications, 2003
- P-Glycoprotein Limits the Brain Penetration of Nonsedating but not Sedating H1-AntagonistsDrug Metabolism and Disposition, 2003
- A randomized, double‐blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine‐induced cutaneous responses in healthy adult volunteersAllergy, 2001
- Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell linesEuropean Journal of Pharmaceutical Sciences, 2000
- Carrier-mediated transport and efflux mechanisms in Caco-2 cellsAdvanced Drug Delivery Reviews, 1996